Taher Nassar

2.3k total citations
51 papers, 1.9k citations indexed

About

Taher Nassar is a scholar working on Pharmaceutical Science, Cancer Research and Molecular Biology. According to data from OpenAlex, Taher Nassar has authored 51 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmaceutical Science, 13 papers in Cancer Research and 11 papers in Molecular Biology. Recurrent topics in Taher Nassar's work include Protease and Inhibitor Mechanisms (13 papers), Advanced Drug Delivery Systems (10 papers) and Drug Solubulity and Delivery Systems (7 papers). Taher Nassar is often cited by papers focused on Protease and Inhibitor Mechanisms (13 papers), Advanced Drug Delivery Systems (10 papers) and Drug Solubulity and Delivery Systems (7 papers). Taher Nassar collaborates with scholars based in Israel, United States and Germany. Taher Nassar's co-authors include Simon Benita, Abd Al‐Roof Higazi, Abdullah Haj‐Yehia, Douglas B. Cines, Sa’ed Akkawi, Khalil Bdeir, Nour Karra, Ouri Schwob, Mark Tarshis and Abraham Nyska and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Taher Nassar

50 papers receiving 1.8k citations

Peers

Taher Nassar
Diana S‐L Chow United States
Steve Weitman United States
Rui Yang China
Vladimir V. Shuvaev United States
Ronald J. Shebuski United States
Qin Lu China
Nan Zheng China
Hanno Huwer Germany
Hannah A. Blair New Zealand
Jing Qi China
Diana S‐L Chow United States
Taher Nassar
Citations per year, relative to Taher Nassar Taher Nassar (= 1×) peers Diana S‐L Chow

Countries citing papers authored by Taher Nassar

Since Specialization
Citations

This map shows the geographic impact of Taher Nassar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taher Nassar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taher Nassar more than expected).

Fields of papers citing papers by Taher Nassar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taher Nassar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taher Nassar. The network helps show where Taher Nassar may publish in the future.

Co-authorship network of co-authors of Taher Nassar

This figure shows the co-authorship network connecting the top 25 collaborators of Taher Nassar. A scholar is included among the top collaborators of Taher Nassar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taher Nassar. Taher Nassar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Frušić‐Zlotkin, Marina, et al.. (2022). The dose-dependent effect of a stabilized cannabidiol nanoemulsion on ocular surface inflammation and intraocular pressure. International Journal of Pharmaceutics. 617. 121627–121627. 21 indexed citations
3.
Biswas, Nikhil, Aiman Abu Ammar, Marina Frušić‐Zlotkin, et al.. (2021). Biodistribution and efficacy of the anticancer drug, oxaliplatin palmitate acetate, in mice. International Journal of Pharmaceutics. 604. 120740–120740. 4 indexed citations
4.
Tam, Connie, et al.. (2021). Topical tacrolimus nanocapsules eye drops for therapeutic effect enhancement in both anterior and posterior ocular inflammation models. Journal of Controlled Release. 333. 283–297. 36 indexed citations
5.
Abd‐Elrahman, Ihab, et al.. (2020). Novel targeted mtLivin nanoparticles treatment for disseminated diffuse large B-cell lymphoma. Oncogene. 40(2). 334–344. 4 indexed citations
6.
Nassar, Taher, et al.. (2015). Improved oral absorption of exenatide using an original nanoencapsulation and microencapsulation approach. Journal of Controlled Release. 217. 202–210. 50 indexed citations
7.
8.
Nassar, Taher, et al.. (2011). High Plasma Levels and Effective Lymphatic Uptake of Docetaxel in an Orally Available Nanotransporter Formulation. Cancer Research. 71(8). 3018–3028. 32 indexed citations
9.
Nassar, Taher, Serge Yarovoi, Rami Abu Fanne, et al.. (2011). Urokinase Plasminogen Activator Regulates Pulmonary Arterial Contractility and Vascular Permeability in Mice. American Journal of Respiratory Cell and Molecular Biology. 45(5). 1015–1021. 19 indexed citations
10.
Fanne, Rami Abu, Taher Nassar, Anwar Rayan, et al.. (2010). Blood–brain barrier permeability and tPA-mediated neurotoxicity. Neuropharmacology. 58(7). 972–980. 67 indexed citations
11.
Harush-Frenkel, Oshrat, Maytal Bivas‐Benita, Taher Nassar, et al.. (2010). A safety and tolerability study of differently-charged nanoparticles for local pulmonary drug delivery. Toxicology and Applied Pharmacology. 246(1-2). 83–90. 71 indexed citations
12.
Nassar, Taher, et al.. (2008). A Novel Nanocapsule Delivery System to Overcome Intestinal Degradation and Drug Transport Limited Absorption of P-glycoprotein Substrate Drugs. Pharmaceutical Research. 25(9). 2019–2029. 31 indexed citations
13.
Nassar, Taher, et al.. (2008). The influence of cationic lipid type on in-vitro release kinetic profiles of antisense oligonucleotide from cationic nanoemulsions. European Journal of Pharmaceutics and Biopharmaceutics. 70(1). 248–259. 37 indexed citations
14.
Armstead, William M., Taher Nassar, Sa’ed Akkawi, et al.. (2006). Neutralizing the neurotoxic effects of exogenous and endogenous tPA. Nature Neuroscience. 9(9). 1150–1155. 60 indexed citations
15.
Akkawi, Sa’ed, Taher Nassar, Mark Tarshis, Douglas B. Cines, & Abd Al‐Roof Higazi. (2006). LRP and αvβ3mediate tPA activation of smooth muscle cells. American Journal of Physiology-Heart and Circulatory Physiology. 291(3). H1351–H1359. 43 indexed citations
16.
Goldstein, D. J., Taher Nassar, Grégory Lambert, Jean Kadouche, & Simon Benita. (2005). The design and evaluation of a novel targeted drug delivery system using cationic emulsion–antibody conjugates. Journal of Controlled Release. 108(2-3). 418–432. 24 indexed citations
17.
Heyman, Samuel N., Taher Nassar, Ahuva Shina, et al.. (2004). The fibrinolytic system attenuates vascular tone: effects of tissue plasminogen activator (tPA) and aminocaproic acid on renal microcirculation. British Journal of Pharmacology. 141(6). 971–978. 12 indexed citations
18.
Nassar, Taher, et al.. (2002). Effects of the superoxide dismutase-mimetic compound tempol on endothelial dysfunction in streptozotocin-induced diabetic rats. European Journal of Pharmacology. 436(1-2). 111–118. 74 indexed citations
19.
Nassar, Taher, Abdullah Haj‐Yehia, Sa’ed Akkawi, et al.. (2002). Binding of Urokinase to Low Density Lipoprotein-related Receptor (LRP) Regulates Vascular Smooth Muscle Cell Contraction. Journal of Biological Chemistry. 277(43). 40499–40504. 47 indexed citations
20.
Haj‐Yehia, Abdullah, et al.. (2000). Determination of lipoic acid and dihydrolipoic acid in human plasma and urine by high-performance liquid chromatography with fluorimetric detection. Journal of Chromatography A. 870(1-2). 381–388. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Diana S‐L Chow Breakdown of academic impact, for papers by Steve Weitman Breakdown of academic impact, for papers by Rui Yang Breakdown of academic impact, for papers by Vladimir V. Shuvaev Breakdown of academic impact, for papers by Ronald J. Shebuski Breakdown of academic impact, for papers by Qin Lu Breakdown of academic impact, for papers by Nan Zheng Breakdown of academic impact, for papers by Hanno Huwer Breakdown of academic impact, for papers by Hannah A. Blair Breakdown of academic impact, for papers by Jing Qi
Rankless by CCL
2026